Medicine and Dentistry
Ganglioglioma
100%
Celecoxib
57%
Patient
42%
Cell Proliferation
28%
Programmed Cell Death
28%
Survivin
28%
Recurrent Disease
14%
Combination Therapy
14%
Metastatic Carcinoma
14%
Antineoplastic Activity
14%
Prostaglandin E2
14%
Malignant Neoplasm
14%
Glioma Cell
14%
Drug Therapy
14%
Cell Cycle Arrest
14%
Cyclooxygenase 2 Inhibitor
14%
Glioma Cell Line
14%
Drug
14%
Brain Cell
14%
Chemotherapeutic Agent
14%
Therapeutic Procedure
14%
Brain Tissue
14%
Neuroscience
Glioma
71%
Celecoxib
57%
Cell Proliferation
28%
Apoptosis
28%
Survivin
28%
Metastasis
14%
Cell Cycle Arrest
14%
Prostaglandin E2
14%
COX-2 Inhibitor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Glioma
100%
Celecoxib
57%
Survivin
28%
Recurrent Disease
14%
Prostaglandin E2
14%
Metastasis
14%
Malignant Neoplasm
14%
Drug
14%
Biochemistry, Genetics and Molecular Biology
Celecoxib
57%
Cell Proliferation
28%
Apoptosis
28%
Survivin
28%
Electric Potential
14%
Cell Cycle Arrest
14%
Prostaglandin E2
14%
Antineoplastic Activity
14%
Sample
14%
Dose
14%
Immunology and Microbiology
Cell Proliferation
28%
Apoptosis
28%
Electric Potential
14%
Prostaglandin E2
14%
Antineoplastic Activity
14%
Brain Cell
14%
Cell Cycle Arrest
14%
Glioma Cell
14%
Dose
14%
Sample
14%
Brain Tissue
14%
Glioma Cell Line
14%